Gains in the current understanding of managing neovascular AMD with brolucizumab

BACKGROUND: Unresolved retinal fluid and high injection burden are major challenges for patients with neovascular age-related macular degeneration. Brolucizumab addresses these challenges by providing robust vision gains and superior fluid resolution, with the potential for longer treatment interval...

Descripción completa

Detalles Bibliográficos
Autores principales: Bodaghi, Bahram, Khanani, Arshad M., Khoramnia, Ramin, Pavesio, Carlos, Nguyen, Quan Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10667168/
https://www.ncbi.nlm.nih.gov/pubmed/37995057
http://dx.doi.org/10.1186/s12348-023-00369-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10667168/
https://www.ncbi.nlm.nih.gov/pubmed/37995057
http://dx.doi.org/10.1186/s12348-023-00369-8

Ejemplares similares